BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT - Free Report) - HC Wainwright cut their FY2026 earnings per share (EPS) estimates for shares of BridgeBio Oncology Therapeutics in a report issued...
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) used a presentation at Leerink Partners' Global Healthcare Conference to outline its strategy around next-generation RAS therapeutics, highlighting three...